
Sign up to save your podcasts
Or


In this cutting-edge episode, Yosef Refaeli, Ph.D, co-founder and CEO
of Ascensus Therapeutics, reveals how a lab accident led to a
breakthrough in regenerative medicine that’s transforming longevity
and cancer treatment. From eliminating solid tumors to reversing
immune system aging and restoring vitality in humans (and even dogs),
Dr. Refaeli explains how harnessing the body’s own immune cells could
rewrite the future of health.
Whether you’re curious about revolutionary cancer therapies or how to
turn back your biological clock, this episode dives deep into the
science of staying “forever young.”
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Cloud104.3
5252 ratings
In this cutting-edge episode, Yosef Refaeli, Ph.D, co-founder and CEO
of Ascensus Therapeutics, reveals how a lab accident led to a
breakthrough in regenerative medicine that’s transforming longevity
and cancer treatment. From eliminating solid tumors to reversing
immune system aging and restoring vitality in humans (and even dogs),
Dr. Refaeli explains how harnessing the body’s own immune cells could
rewrite the future of health.
Whether you’re curious about revolutionary cancer therapies or how to
turn back your biological clock, this episode dives deep into the
science of staying “forever young.”
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices

7,201 Listeners

5,005 Listeners

1,810 Listeners

1,143 Listeners

3,436 Listeners

4,913 Listeners

3,530 Listeners

9,245 Listeners

1,369 Listeners

1,050 Listeners

4,075 Listeners

195 Listeners

632 Listeners

632 Listeners

85 Listeners

291 Listeners

2,240 Listeners

1,056 Listeners

1,675 Listeners

930 Listeners

411 Listeners

319 Listeners

20 Listeners

96 Listeners

73 Listeners

20 Listeners

94 Listeners

21 Listeners

15 Listeners

0 Listeners

20 Listeners

20 Listeners

26 Listeners

11 Listeners